EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)

https://storage.unitedwebnetwork.com/files/1099/3e3d1d65009e68f679606c1cb66c7c49.pdf
EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)
Lucia
Quintana-Gallardo
Andrew Bomback asb68@cumc.columbia.edu Columbia University, Irving Medical Center NA New York
Erica Daina erica.daina@marionegri.it Istituto di Ricerche Farmacologiche Mario Negri, IRCCS NA Bergamo
John Kanellis john.kanellis@monash.edu Monash Medical Centre NA Clayton
David Kavanagh david.kavanagh@newcastle.ac.uk National Renal Complement Therapeutics Centre, Newcastle University NA Newcastle
Matthew C. Pickering matthew.pickering@imperial.ac.uk Imperial College NA London
Gere Sunder-Plassmann gere.sunder-plassmann@meduniwien.ac.at Medical University of Vienna NA Vienna
Patrick Walker patrick.walker@arkanalabs.com Arkana Laboratories NA Little Rock
Zhongshen Wang zhongshen.wang@apellis.com Apellis Pharmaceuticals, Inc NA Waltham
Zurish Ahmad zurish.ahmad@apellis.com Apellis Pharmaceuticals, Inc NA Waltham
Fadi Fakhouri fadi.fakhouri@unil.ch Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois NA Lausanne
 
 
 
 
 
E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos